Table 1.
Peptide | Sequence | Heart Rate | Diastolic Interval | Systolic Interval | Fractional Shortening | Arrhythmicity Index |
---|---|---|---|---|---|---|
AKH | QLTFSPDWa | / | / | / | / | / |
AstA1 | VERYAFGLa | / | / | / | + | / |
AstA2 | LPVYNFGLa | / | - | + | / | / |
AstA3 | SRPYSFGLa | / | / | / | / | / |
AstA4 | TTRPQPFNFGLa | Θ | Θ | Θ | Θ | Θ |
Corazonin | QTFQYSRGWTNa | ++ | -- | + | / | / |
DH31 | TVDFGLARGYSGTQEAKHRMGLAAANFAGGPa | +++ | - | -- | / | / |
DSK1 | FDDYGHMRFa | / | / | / | / | / |
DSK2 | GGDDQFDDYGHMRFa | / | / | / | / | / |
Leucokinin | NSVVLGKKQRFHSWGa | / | / | / | + | / |
Proctolin | RYLPT | +++ | --- | / | / | + |
sNPF11-11 | AQRSPSLRLRFa | / | / | / | / | / |
sNPF14-11 sNPF212-19 | SPSLRLRFa | / | / | / | / | / |
Tachykinin 1 | APTSSFIGMRa | +++ | -- | / | / | + |
Tachykinin 2 | APLAFVGLRa | / | / | / | / | / |
Tachykinin 3 | APTGFTGMRa | + | / | / | / | / |
Tachykinin 4 | APVNSFVGMRa | / | / | / | / | ++ |
Tachykinin 5 | APNGFLGMRa | +++ | -- | / | / | / |
Tachykinin 6 | AALSDSYDLRGKQQRFADFNSKFVAVRa | / | / | / | / | / |
Listed are all peptides applied in this study along with their respective sequence and the effects on individual heart parameters (at 1 × 10−7 M). Nomenclature indicates significance of the observed effects (+ = increase, p < 0.05; ++ = increase, p < 0.01; +++ = increase, p < 0.001; - = decrease, p < 0.05; -- = decrease, p < 0.01; --- = decrease, p < 0.001; / = no significant effect; paired sample Student´s t-test). Θ indicates full arrest of heartbeat upon peptide application.